PFM Health Sciences’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-110,600
Closed -$6.57M 91
2023
Q1
$6.57M Sell
110,600
-115,300
-51% -$6.41M 0.29% 62
2022
Q4
$11M Buy
+225,900
New +$10.4M 0.39% 67
2015
Q3
Sell
-965,900
Closed -$3.43M 102
2015
Q2
$3.43M Buy
+965,900
New +$49.3M 0.09% 78

Other funds holding THC

PFM Health Sciences's THC Position: Q1 2026 in Review

PFM Health Sciences increased its Tenet Healthcare (THC) stake by 0.2% in Q1 2026, buying an estimated $169K and bringing the position to 398,567 shares worth $75.2M. The position accounts for 6.86% of the portfolio, ranked #1.

PFM Health Sciences first reported a position in THC in Q3 2013 and has held it in 37 quarters since. The position peaked at $146M in Q2 2018. 691 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • PFM Health Sciences held 398,567 shares of Tenet Healthcare worth $75.2M as of Q1 2026.
  • PFM Health Sciences bought 800 Tenet Healthcare shares in Q1 2026, an estimated $169K.
  • Tenet Healthcare made up 6.86% of PFM Health Sciences's portfolio in Q1 2026, its #1 holding.
  • PFM Health Sciences first reported a position in Tenet Healthcare in Q3 2013 and has held it in 37 quarters since.
  • PFM Health Sciences's Tenet Healthcare position peaked at $146M in Q2 2018.
  • 691 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.